MedPath

GLICLAZIDA SANDOZ 30 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

GLICLAZIDA SANDOZ 30 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Commercialized
Register Number

79929

Prescription Type

Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración

Authorization Date

Jun 9, 2015

Dosage Form

COMPRIMIDO DE LIBERACIÓN MODIFICADA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number79929
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

GLICLAZIDAActive
Quantity: 30,00 mg
Name: GLICLAZIDA

ATC CLASSIFICATION (3)

A10B
A10BB
A10BB09

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.